Immuneering shareholders elect two Class I directors and ratify auditor RSM US LLP

Immuneering Corp

Ann E. Berman and Diana F. Hausman, M.D. elected as Class I directors with over 18M votes each.
Ratification of RSM US LLP as auditor for FY2022 passed with 20,719,504 votes for, 30 against, 1,100 abstained.
Quorum of 20,720,634 shares (78.5% of outstanding) present at June 21, 2022 Annual Meeting.
No other proposals were voted on at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.